New Celadrin® & MSM from NOW is scientifically formulated to provide superior joint support by combining two effective and clinically tested compounds. Celadrin® is a proprietary esterified fatty acid complex that has been shown to help support healthy joint function and mobility without the adverse side effects often associated with other therapies. Scientific studies indicate that Celadrin® is a safe, well-absorbed joint-supporting agent that is easily utilized by the body.
Celadrin and MSM Fact Sheet
Neil E. Levin, CCN, DANLA
LIKELY USERS: People lacking flexibility or mobility; People wanting temporary control of aches and pains; People wanting to reduce pro-inflammatory body chemicals
KEY INGREDIENT(S): Celadrin 500 mg.
MAIN PRODUCT FEATURES: CELADRIN is an all-natural proprietary matrix of esterified (cetylated) fatty acid carbons (EFAC) derived from tallow of USA-raised cattle. This product is developed through a proprietary process of esterifying oil & has been clinically tested. Celadrin promotes joint health by improving flexibility, painmanagement and mobility. The myristoleic acids and the cetylated forms may alter the 5-LOXenzyme and change the leukotriene production, inhibiting inflammatory compounds.
Celadrin may offer some noticeable benefits faster than other substances,like glucosamine and chondroitin. It is not a substitute for these important nutrients, though.
OTHER IMPORTANT ISSUES: MSM has synergistic abilities to reduce certain substances in the body which may affect inflammation.
AMOUNT and HOW TO USE: Three capsules a day, preferably with meals.
SYNERGISTS: Glucosamine, Chondroitin, MSM, Joint Support Products, Manganese, Vitamin C, other Antioxidants
CAUTIONS: Please notify your physician about your supplement use if you are using any drugs!
1. J Rheumatol. 2002 Aug;29(8):1708-12. Cetylated fatty acids improve knee function in patients with osteoarthritis. Hesslink R Jr, Armstrong D 3rd, Nagendran MV, Sreevatsan S, Barathur R.
2. Anticancer Res. 2003 Jan-Feb;23(1A):453-8. Aspirin and methylsulfonylmethane (MSM): a search for common mechanisms, with implications for cancer prevention. Ebisuzaki K.
3. J Altern Complement Med. 2002 Apr;8(2):167-73. A multicentered, open-label trial on the safety and efficacy of methylsulfonylmethane in the treatment of seasonal allergic rhinitis. Barrager E, Veltmann JR Jr, Schauss AG, Schiller RN. (allergy related inflammation